Home -> Law Blog Directory -> Litigation Blogs -> How Appealing
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Litigation
: How AppealingFederal Circuit rejects challenge to the validity of the patent for the drug Plavix
Full post as published by How Appealing on December 12, 2008 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Privacy Protection Act 42 USC 21A
Federal Newsroom Law
Federal Adoption Tax Credit
Financial Incentive for Adoptive Parents
Transportation Equity Act for the 21st Century
TEA-21 - Plus Law 105-178
Specialty Lamp International
Recalls Counterfeit Circuit Breakers
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Clopidogrel Marketed as Plavix FDA Issues Public Health Advisory
Clopidogrel Marketed as Plavix FDA Issues Public Health Advisory
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
Plavix and Nexium
A Potentially Dangerous Combination
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.

Canadian Supreme Court Confirms Plavix Patent Despite Evergreening Charges
Federal Circuit Affirms Validity and Enforceability of Eisai's Compound Patent on Aciphex
Our pro-patent neighbors to the North deliver a victory for big Pharma
1st Circuit rejects Dont Ask, Dont Tell challenge








